These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25733677)

  • 41. Ethical issues in administrative continuous improvement. Applying the concept of prior notification to the conduct of firm trials.
    Goldberg HI
    Med Care; 1990 Sep; 28(9):822-33. PubMed ID: 2205768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loopholes in the Research Ethics System? Informed Consent Waivers in Cluster Randomized Trials with Individual-Level Intervention.
    London AJ; Taljaard M; Weijer C
    Ethics Hum Res; 2020 Nov; 42(6):21-28. PubMed ID: 33136332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the role and authority of gatekeepers in cluster randomized trials in health research?
    Gallo A; Weijer C; White A; Grimshaw JM; Boruch R; Brehaut JC; Donner A; Eccles MP; McRae AD; Saginur R; Zwarenstein M; Taljaard M
    Trials; 2012 Jul; 13():116. PubMed ID: 22834691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans.
    Mazor KM; Sabin JE; Boudreau D; Goodman MJ; Gurwitz JH; Herrinton LJ; Raebel MA; Roblin D; Smith DH; Meterko V; Platt R
    Med Care; 2007 Oct; 45(10 Supl 2):S29-37. PubMed ID: 17909379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care.
    Eldridge SM; Ashby D; Feder GS
    Clin Trials; 2005; 2(2):91-8. PubMed ID: 16279130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ethics of cluster randomized trials: response to a proposal for revision of the Ottawa Statement.
    Weijer C; Taljaard M
    J Clin Epidemiol; 2019 Dec; 116():140-145. PubMed ID: 31449857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethical and legal issues in emergency research: barriers to conducting prospective randomized trials in an emergency setting.
    Morrison CA; Horwitz IB; Carrick MM
    J Surg Res; 2009 Nov; 157(1):115-22. PubMed ID: 19765724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight.
    Whicher D; Kass N; Saghai Y; Faden R; Tunis S; Pronovost P
    J Empir Res Hum Res Ethics; 2015 Apr; 10(2):132-44. PubMed ID: 25742674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges in the research ethics review of cluster randomized trials: international survey of investigators.
    Chaudhry SH; Brehaut JC; Grimshaw JM; Weijer C; Boruch R; Donner A; Eccles MP; McRae AD; Saginur R; Skea ZC; Zwarenstein M; Taljaard M
    Clin Trials; 2013 Apr; 10(2):257-68. PubMed ID: 23539109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gatekeepers for pragmatic clinical trials.
    Whicher DM; Miller JE; Dunham KM; Joffe S
    Clin Trials; 2015 Oct; 12(5):442-8. PubMed ID: 26374683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Participants' written informed consent in low-risk pragmatic clinical trials with medicines.
    Dal-Ré R
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):205-210. PubMed ID: 32073940
    [No Abstract]   [Full Text] [Related]  

  • 54. Are distinctive ethical principles required for cluster randomized controlled trials?
    Hutton JL
    Stat Med; 2001 Feb; 20(3):473-88. PubMed ID: 11180314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings.
    Joag K; Ambrosio G; Kestler E; Weijer C; Hemming K; Van der Graaf R
    Trials; 2019 Dec; 20(Suppl 2):703. PubMed ID: 31852547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized trials in vulnerable populations.
    Cook D; Moore-Cox A; Xavier D; Lauzier F; Roberts I
    Clin Trials; 2008; 5(1):61-9. PubMed ID: 18283082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials.
    McKenzie JE; Herbison GP; Roth P; Paul C
    Trials; 2010 Mar; 11():28. PubMed ID: 20302671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.